Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Deep Dive: Upper Digestive Cancers - Pancreatic Cancer: From Molecule To Medicine

ESMO-Deep-Dive-Upper-Digestive-Cancers-1000x250-Pancreatic-Cancer
Live on
15 Jun 2022 at 18:30 CEST

It is with great pleasure that we invite you to participate in the ESMO Deep Dive Webinar on pancreatic cancer, elaborating the facts from molecule to medicine.

This webinar is developed with the aim to understand different types of models for studying pancreatic cancer along their limitations, to review KRAS targeting and the current pre-clinical and early clinical approaches, discuss homologous repair deficiency, immunotherapy and other novel pathways targeting in pancreatic cancer, and to understand how the genomic and biologic underpinnings of pancreatic cancer are being translated into clinical practice.

We are delighted to announce the distinguished speakers who will join us in this webinar. We will begin with a lecture on best pre-clinical models for pancreatic cancer. This will follow with elaboration of novel KRAS directed therapies for pancreatic cancer. Finally, we will review molecular biology of pancreatic cancer from the aspect of treatment individualisation. The lectures will be followed by a live discussion with the full speakers’ panel.

The programme is designed to provide an overview of the latest understanding of molecular biology and the impact of targeting different pathways in the management of patients with pancreatic cancer, offer expert opinion exchange and provide some important considerations in this field. We strongly encourage and invite you to register and join us all in this new ESMO activity.

Prof. Eileen M. O’Reilly
Memorial Sloan Kettering Cancer Center, New York, United States
Weill Cornell Medical College, Cornell University, New York, United States

AND

Prof. Stefano Cascinu
San Raffaele Hospital, Milan Italy

Speakers

Programme

Time

Title

Speaker

5 min

Welcome and Introduction

Eileen O’Reilly, Stefano Cascinu

25 min

What are the best pre-clinical models for pancreatic cancer?

Kenneth Olive

25 min

Novel KRAS directed therapies in pancreatic cancer

Andrew Aguirre

25 min

Molecular tumour biology and treatment individualisation: hope or hype?

Thomas Seufferlein

15 min

LIVE Q&A

All

A certificate of attendance and 2 ESMO-MORA category 1 points will be awarded for live attendance at this event

Learning objectives:

  • To understand different types of models for pancreatic cancer along limitations
  • To review KRAS targeting and the pre-clinical and early clinical approaches currently in development for pancreatic cancer
  • To discuss homologous repair deficiency, immune therapy and other novel pathways targeting in pancreatic cancer
  • To understand how the genomic and biologic underpinnings of pancreatic cancer are being translated into practice

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.